Company Femtobiomed Inc.

Equities

A327610

KR7327610002

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Sector Other Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
8,200 ^KRW	-0.36%		-6.07%	+47.48%

Apr. 23	Femtobiomed Inc. announced that it has received KRW 2.999996625 billion in funding from Korea Investment Partners Co. Ltd.	CI
Mar. 25	Femtobiomed Inc. announced that it expects to receive KRW 2.999996625 billion in funding from Korea Investment Partners Co. Ltd.	CI

Femtobiomed Inc. is a Korea-based company principally work on the research and development of natural science and engineering. The Company is engaged in the development and manufacture of anticancer vaccines through its platform called CELLSHOT.

KRW in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical 100.0 %	183	100.0 %	334	100.0 %	+82.12%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	159	86.7 %	334	100.0 %	+109.99%

Managers	Title	Age	Since
Sang-Hyeon Lee CEO	Chief Executive Officer	51	-
Hwa-Sub Choi DFI	Director of Finance/CFO	50	-
Joon-Kwon Park CTO	Chief Tech/Sci/R&D Officer	44	-
Jae-Seung Sim AUD	Comptroller/Controller/Auditor	65	-

Members of the board	Title	Age	Since
Sang-Hyeon Lee CEO	Chief Executive Officer	51	-
Joon-Kwon Park CTO	Chief Tech/Sci/R&D Officer	44	-
Wan-Gyun Jung BRD	Director/Board Member	65	-
Hwa-Sub Choi DFI	Director of Finance/CFO	50	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	8,401,272	3,329,282 ( 39.63 %)	85 ( 0.001012 %)	39.63 %

Name	Equities	%	Valuation
Sang-Hyeon Lee 45.48 %	3,820,777	45.48 %	25 M ₩
SV INVESTMENT CORPORATION 5.840 %	490,613	5.840 %	3 M ₩
Hanwha Investment Corp. 4.623 %	388,359	4.623 %	3 M ₩
Hwa-Sub Choi 0.8927 %	75,000	0.8927 %	500 279 ₩
Joon-Kwon Park 0.7808 %	65,600	0.7808 %	437 577 ₩
Sang-gap Bae 0.1789 %	15,030	0.1789 %	100 256 ₩
Wan-Gyun Jung 0.1696 %	14,250	0.1696 %	95 053 ₩
Han-na Bae 0.1057 %	8,880	0.1057 %	59 233 ₩
Ju-hyun Choi 0.000000 %	0	0.000000 %	- ₩

Femtobiomed, Inc.

Unit301, Pangyo Seven Valley 2 17, Pangyo-ro 228beon-gil

13487, Seongnam-si

http://www.femtobiomed.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
FEMTOBIOMED INC.	+47.48%	48.94M
IQVIA HOLDINGS INC.	+1.43%	42.19B
LONZA GROUP AG	+44.30%	40.15B
CELLTRION, INC.	-6.20%	28.31B
ICON PUBLIC LIMITED COMPANY	+6.86%	24.63B
ALNYLAM PHARMACEUTICALS, INC.	-21.90%	18.2B
MEDPACE HOLDINGS, INC.	+29.14%	12.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.13%	11.76B
UNITED THERAPEUTICS CORPORATION	+15.58%	10.4B
BIO-TECHNE CORPORATION	-4.10%	9.94B

Other Biotechnology & Medical Research